11 Investments in associates and joint ventures

11 Investments in associates and joint ventures
CHF million Joint ventures Other companies Total
Carrying amount at 31 December 2007 536 1,248 1,784
Additions 30 446 476
Dividend – 18 – 30 – 48
Share of profit 20 76 96
IAS 39 effects taken to equity   16 16
Effect of IFRS reconciliation for consoli- dation charged / credited to energy costs – 66   – 66
Reclassification (see note 12)   284 284
Disposals   – 7 – 7
Exchange differences   – 139 – 139
Carrying amount at 31 December 2008 502 1,894 2,396
Acquisition / disposal of subsidiaries 3,486 63 3,549
Additions 12 8 20
Dividend – 24 – 32 – 56
Share of profit 24 53 77
IAS 39 effects taken to equity   1 1
Effects charged / credited to energy costs      
IFRS reconciliation for consolidation 13   13
Costs arising from PPA adjustments for EOS (see note 28) – 91   – 91
Reclassification of previous 50 % interest in Emosson (see note 28) – 77   – 77
Reclassification (see note 12)   6 6
Disposals – 3 – 2 – 5
Exchange differences   – 3 – 3
Carrying amount at 31 December 2009 3,842 1,988 5,830
       

All significant associates and joint ventures are valued in accordance with uniform IFRS principles. Reconciliations are prepared in cases where no financial statements prepared under IFRS are available.

The reporting date of a few associates and joint ventures is different from the Group's. The most recent available financial statements of these companies have been used for the Alpiq Group consolidation. Adjustments have been made in the consolidated financial statements for the effects of significant transactions and events that occurred between the most recent financial statements and 31 December.

The market value of the Group's interests in other companies listed on a stock exchange was CHF997 million at 31 December 2009 (31 December 2008: CHF907 million). The carrying amount of these companies was CHF952million at the reporting date (CHF941 million). The Alpiq Group continuously monitors movements in the market value of the listed companies. If the carrying amount exceeds the Group's share of their market value significantly and for a prolonged period, the Group tests the asset for impairment based on approved medium-term plans. The impairment test of listed associates showed no need to recognise an impairment loss at the reporting date on 31 December 2009.

Summarised financial information of associates and joint ventures (Alpiq Group share)

Summarised financial information of associates and joint ventures (Alpiq Group share)
1 Including minority interests.
  Joint ventures Other companies
CHF million 2008 2009 2008 2009
Non-current assets 2,418 6,733 2,958 3,005
Current assets 215 242 703 796
Non-current liabilities 1 1,928 2,779 1,200 1,186
Current liabilities 203 354 567 627
Income 396 702 1,789 1,904
Expenses 1 – 376 – 678 – 1,713 – 1,851
         

Under joint venture agreements in force, the shareholders of joint ventures are required to pay the annual costs attributable to their percentage ownership interests (incl. interest and repayment of liabilities). The Alpiq Group's share of the regular annual costs in 2009 was CHF630 million (2008: CHF345 million).

In addition, nuclear power plant owners are required to pay limited additional contributions to the decommissioning and waste disposal fund in the event that any one primary contributor is unable to make its payments.